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1. Introduction 
Bleomycin is a glycopeptide antibiotic with 
antineoplastic activity in a variety of human neoplasms 
(Lazo and Chabner, 1996). It is usually administered as a 
part of combination chemotherapy regimens either as a 
single dose or as a fractionated dose. However, the 
effective use of BLM in chemotherapy is greatly limited, 
since it causes a dose-dependent interstitial pneumonitis 
that  often  progresses  to interstitial pulmonary fibrosis  
(Venkatesan et al., 1997). This is due to the lack of the 
BLM-inactivating enzyme, bleomycin hydrolase, in the 
lungs. The primary mechanism by which BLM induces 
pulmonary toxicity is thought to be related to redox 
cycling of an iron-BLM complex that catalyzes the 
formation of superoxide and hydroxyl radicals and 
causes DNA strand scission and lipid peroxidation.  
Hyperpyrexia, shock and death following initial 
injection of BLM (7.5 units) for a poorly differentiated 
metastatic carcinoma was reported in some cases (Levy 
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and Chiarillo, 1980). Leung et al. (1989) described a fatal 
hyperpyrexial reaction after bleomycin in a patient with 
T-cell lymphoma who had had no febrile response when 
receiving initial injection 3 weeks earlier. Paracetamol 
inhibits the synthesis of prostaglandins centrally, having 
an analgesic antipyretic but not anti-inflammatory effect 
(Doherty et al., 1990; Woollard et al., 1990). 
The present study was undertaken to investigate 
whether paracetamol could modify the antitumor 
activity of BLM in vitro and in vivo against Ehrlich Ascites 
Carcinoma (EAC) cells. Moreover, its effect on lung 
toxicity produced by BLM was also studied. Firstly, by 
measuring the effect of chronic treatment with this 
combination on the response of the isolated pulmonary 
arterial rings and tracheal strips to 5-HT and ACh, 
respectively, as pharmacological markers of lung injury. 
Secondly, by measuring some biochemical parameters 
which reflect the severity of lung injury such as 
hydroxyproline level, lipid peroxidation, nitric oxide 
(NO), superoxide dismutase (SOD) activity and reduced 
glutathione level (GSH). 
 
2. Materials and Methods 
 
2.1. Experimental animals 
Female Swiss albino mice weighing 20-30 g were 
used to study the cytotoxic effect of BLM alone and in 
combination with paracetamol. Sprague-Dawley rats of 
either sex weighing 110-160 g were used for evaluating 
lung toxicity. The experiments were conducted in 
accordance with the ethical guidelines for investigations 
in laboratory animals and were approved by the Ethical 
Committee of Faculty of Pharmacy, Mansoura University, 
Egypt. 
 
2.2. Drugs and chemicals 
Bleomycin (BLM): as a white powder was obtained 
as a generous gift from Dr. Hiroshi Suda (Nippon Kayaku 
Co., LTD., Tokyo, Japan); Paracetamol: as a white 
powder was obtained from Sigma Aldrich chemical Co. 
(St. Louis, MO, USA); Roswell Park Memorial Institute 
(RPMI 1640) Medium (supplied by Sigma Aldrich 
chemical Co.); All other chemicals used in this study are 
of fine analytical grade. 
 
2.3. Ehrlich Ascites Carcinoma Cells 
Ehrlich ascites carcinoma cells were established in 
the Netherlands Cancer Institute. The Ehrlich tumor line 
was maintained in the laboratory of Faculty of Pharmacy, 
Mansoura University in female Swiss albino mice by 
serial intraperitoneal passage at 7-10 day intervals as 
described by Geran et al. (1972). 
 
2.4.  Cytotoxicity study 
2.4.1. In vitro experiment 
 Cell culture. EAC cells suspended in RPMI 1640 
medium supplemented with 10% fetal calf serum, 
containing various concentrations of drugs were 
cultured in cell culture sterile tubes at a density of 2 X 105 
cells/ml/tube.  The tubes were incubated in a humidified 
atmosphere containing 5% CO2 at 37
oC for 24 h. The 
trypan blue dye exclusion test was used to determine 
the rate of cellular growth inhibition. The dye stains the 
dead cells only (Weisenthal et al., 1983). 
In vitro cytotoxic assay. Ascitic fluid from the 
intraperitoneal cavity of the donor animal was 
aseptically aspirated, 7-8 days after EAC cells inoculation, 
and washed three times with N-2-hydroxyethyl-
piperazine-N-2-ethanesulfonic acid buffered Hanks’ 
balanced salt solution. EAC cells were counted under the 
microscope using a haemocytometer and resuspended 
in normal saline so that each 0.1 ml contained 2 X 105 cells 
(Badary et al., 2000). EAC cells were incubated in RPMI 
1640 medium for 24 h in cell culture tubes, each tube 
contained 0.1 ml cells and 0.9 ml medium (final 
concentration of the cells = 2 X 105 cells/ml). After 24-h 
incubation, the tubes were centrifuged at 1000 r.p.m. 
and cells were separated. EAC cells were resuspended in 
RPMI 1640 medium and drugs were added so that the 
content of each tube was 0.8 ml medium, 0.1 ml cells and 
0.1 ml drug. The final drug concentrations of BLM were 
25, 50, 100 and 200 g.ml-1.  
The cytotoxicity dose response curve for BLM was 
constructed in order to determine the concentration 
that inhibits 50% of cell survival (IC50). EAC cells were 
incubated with 50 g/ml BLM (IC50), paracetamol (400 
g/ml, Hayes et al., 1984), or their combination for 24 h. 
After incubation of cells with drugs, cells were 
separated, washed by PBS and resuspended in a drug-
free medium. EAC cells were stained with trypan blue 
dye and the percent survival of cells was determined by 
trypan blue dye exclusion method. Cytotoxicity was 
determined 3 times and the mean was recorded.  
Control experiments in which EAC cells were 
incubated in a drug-free medium were also conducted. 
Percent survival of cells = (T/C) X 100 was calculated 
where T and C represent the number of viable cells in a 
unit volume of the test drug tube and the control tube, 
respectively. 
 
2.4.2. In vivo experiment 
Ascitic fluid was withdrawn under aseptic 
conditions from tumor-bearing mice by needle aspiration 
from the peritoneal cavity, 7-8 days after EAC cells 
inoculation, and washed three times with normal saline 
by centrifugation at 1000 r.p.m. EAC cells obtained after 
washing were tested for viability using trypan blue. The 
cells were examined microscopically using a 
haemocytometer, suspended in normal saline so that 
each 0.1 ml contained 5 X 105 viable EAC cells. The cells 
were counted under the microscope.  
Solid tumors were induced in mice by S.C 
inoculation of 0.1 ml containing 5 X 105 viable tumor cells 
on the left flank anterior to the hind leg (Raja Naresh et 
al., 1996). Tumor growth was determined by caliper 
measurement of the largest diameter and its 
perpendicular (Schirner et al., 1998).   
Tumor size (mm3) = 0.5 X  a  X  b2. 
Where a is the largest diameter and b is its 
perpendicular. 
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When the primary tumor reached a size of 50-100 
mm3, 40 mice were grouped into 4 groups (10 mice 
each). Group (1) received normal saline (EAC-bearing 
control, 5 mg/kg). Group (2) received BLM (5 mg/kg from 
0.1% solution) I.P every other day for 10 days. Group (3) 
received paracetamol (200 mg/kg, orally, Hunskaar et al., 
1985) for 10 consecutive days. Group (4) received BLM 
and paracetamol. Tumor size before (day 0, five days 
after tumor inoculation) and after treatment (day 10, 
fifteen days after tumor inoculation) was measured. 
Antitumor activity was calculated by the determination 
of T (change of tumor size in the treatment group) and 
C (change of tumor size in the control). The degree of 
tumor growth inhibition can be obtained from T/C X 
100 (Schirner et al., 1998).   
 
2.4.3. Lung toxicity 
Rats were grouped into 4 groups of 8 rats each. 
Group (1) received normal saline (2.5 mg/kg). Group (2) 
received BLM (mg/kg from 0.5% solution) I.P. three 
times/week for 4 weeks (Daba et al., 2002). Group (3) 
received paracetamol (150 mg/kg, orally, Chattopadhyay 
et al., 2002) daily for 4 weeks [13]. Group (4) received 
BLM and paracetamol. Twenty-four hours after the last 
dose of the specific treatment, all rats were weighed and 
then sacrificed by cervical dislocation. The pulmonary 
arteries, trachea and lungs were rapidly excised.  
The vasoconstrictor effect of 5-HT on the 
pulmonary artery and the contractile response to ACh on 
trachea were tested. The percent survival of rats was 
also recorded at the end of treatment (after 4 weeks). 
Total lungs were weighed for determination of 
lung/body weight ratio. Sections of the isolated lungs, 
each weighing 100 mg, were then used for estimating 
collagen contents, while the other biochemical 
parameters (Lipid peroxide, nitrate/nitrite level, 
superoxide dismutase activity and GSH) were assessed in 
the lung homogenates. All died animals in the survival 
test were replaced to complete 8 rats/each group for 
other tests. 
 
2.4.4. Preparation of pulmonary arterial rings 
Segments of the main pulmonary artery were 
rapidly placed in warm physiological salt solution (PSS) 
(Kreb’s Henseleit) and dissected free of surrounding 
tissue. The composition of PSS in mmol/L was NaCl 118; 
KCl 4.7; CaCl2 2.5; KH2PO4 1.2; MgSO4.7H2O 1.2; NaHCO3 25 
and glucose 10; pH 7.4 (Blom-Muilwijk et al., 1988). The 
pulmonary artery was trimmed and cut into rings about 2 
mm in length. The rings were mounted horizontally 
between a clamp and a force transducer in an organ 
bath filled with 50 ml of the PSS. The PSS was kept at 
37oC and continuously bubbled with a mixture of 95% O2 
and 5% CO2. The suspended pulmonary arterial rings 
were allowed to equilibrate for 30 min under a resting 
load of 3 g (El-Kashef, 1996). 
The isometric tension was monitored by means of 
a displacement transducer (model 50-7905, Harvard 
Apparatus LTD., South Natick, MA, USA) connected to a 
two-channel physiograph recorder (model 50-8622, 
Harvard Apparatus LTD., USA). The contractile responses 
of the pulmonary arterial rings of each group of animals 
to different concentrations of 5-HT ranging from 10-7 to 
10-5 M were recorded. The vascular responsiveness of the 
tissues to 5-HT was calculated after weighing the rings as 
g tension/g tissue. 
 
2.4.5. Preparation of trachea 
The trachea was rapidly removed, placed in Kreb’s 
Henseleit solution gassed with 95% O2 / 5% CO2 and kept 
at 32oC. The Zig-Zag tracheal strips (Emmerson and 
Mackay, 1979) were then prepared. The tracheal tension 
was set at 1 g and a stabilization period of 1 h, was 
allowed before treatment with drugs. The contractile 
responses of the trachea of each group of animals to 
different concentrations of ACh ranging from 10-6 to 10-4 
M were recorded. The trachea was weighed and the 
responsiveness to ACh was calculated as g tension/g 
tissue. 
 
2.4.6. Biochemical measurements 
 
2.4.6.1 Determination of collagen 
The collagen content in lung was assayed 
indirectly as its hydrolytic product, hydroxyproline, HP 
(Woessner, 1961). The absorbance was read at 557 nm 
using colorimeter WPA colourwave (Model CO 7500, 
Cambridge, England) and the concentrations of collagen 
were calculated as mg HP/g wet tissue. 
 
2.4.6.2 Preparation of lung homogenate 
The isolated lungs were rinsed in chilled 1.15 % KCl 
(pH 7.4) and weighed quickly. Subsequently, the 
lung/body weight ratio was determined.  
Homogenization was carried out in ice-cold KCl (1.15%, pH 
7.4) to yield 10% w/v tissue homogenates (Daba et al., 
2002) and the following biochemical parameters were 
assessed. 
 
2.4.6.3 Determination of Lipid peroxidation (LP) 
 The level of LP in the lung was estimated as 
thiobarbituric acid reactive substances (Ohkawa et al., 
1979). The absorbance was determined at 532 nm 
spectrophotometerically and the concentrations were 
expressed as nmol/g wet tissue. 
 
2.4.6.4 Determination of reduced glutathione (GSH) 
 The level of acid-soluble thiols, mainly GSH, in the 
lung was assayed colourmetrically, based on its reaction 
with Ellman’s reagent (1959). The absorbance was 
measured at 412 nm and the concentrations were 
expressed mol/g wet tissue.  
 
2.4.6.5 Determination of superoxide dismutase (SOD) 
 The enzymatic activity of SOD was assessed 
according to Marklund (1985). SOD activity was 
expressed as U/g wet tissue. One unit of SOD activity is 
defined as the amount of the enzyme causing 50% 
inhibition of auto-oxidation of pyrogallol. 
 
2.4.6.6 Determination of nitric oxide (NO) 
 The total amount of NO produced in the lung was 
indirectly estimated as the main metabolites, nitrate and 
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nitrite.  After the conversion of nitrate to nitrite by 
enzyme nitrate reductase in the presence of the cofactor 
NADPH, NO was collectively determined as nitrite by the 
Griess reaction. In acid solution, nitrite is converted to 
nitrous acid (HNO2) which diazotizes sulfanilamide. This 
sulfanilamide-diazonium salt then reacts with N- (1-
Naphthyl)-ethylenediamine dihydrochloride (NEDA) to 
produce a chromophore which is measured at 540 nm 
and the concentrations of NO were calculated as mol of 
nitrite and nitrate/g wet tissue (Tracy et al., 1995).  
 
2.5 Statistical analysis 
Data are expressed as mean  S.E.M. (Significance 
was calculated at p0.05). Statistical analysis was carried 
out using one way analysis of variance (ANOVA) 
followed by Tukey-Kramer multiple comparisons test , in 
addition to linear regression analysis for the best fitting 
line of all standard points (Daniel, 1991). Also paired 
Student’s t-test was used as a test of significance for 
comparison between two arithmetic means of the same 
subject before and after treatment (Daniel, 1991). Chi-
square test was used for comparison of two proportions 
(Daniel, 1991). Statistical calculations were carried out 
using Instat-2 computer program (GraphPad Software 
Inc. V2.04, San Diego, CA, USA). 
 
3. Results 
 
3.1. Effect of paracetamol on the cytotoxic effect of 
BLM on cultured EAC cells 
The IC50 of BLM was found to be about 50 μg/ml. 
The cytotoxic effect of paracetamol was studied and the 
results showed no significant difference from the 
control. Combinations of BLM with paracetamol showed 
a significant difference when compared to the control 
group but non-significant when compared to BLM alone 
(table 1). 
 
Table 1. Effect of paracetamol (400 g/ml) on the cytotoxic effect of 
BLM (50 mg/ml) on cultured EAC cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significantly different from control group using One-
Way ANOVA followed by Tukey-Kramer multiple 
comparisons test (p<0.05). 
 
3.2. Effect of bleomycin and/or paracetamol on 
tumor size after 10 days treatment 
Implantation of EAC cells resulted in a solid 
palpable tumor mass that appeared after 5 days from 
inoculation (day 0). The size of tumor progressively 
increased with time and reached about 3.5-folds its initial 
mass after additional 10 days (day 10) that considered 
100% tumor growth.  
Treatment with BLM significantly decreased the 
relative tumor size compared to the control group, 
showing 19% tumor growth (i.e. 81% tumor growth 
inhibition). Mice treated with paracetamol showed a 
similar pattern like the control group. Administration of 
BLM with paracetamol showed an increase in tumor 
growth by only 7% (i.e. 93% tumor growth inhibition) 
compared to the control group with no significant 
difference from BLM group (table 2). 
 
Table 2.    Effect of bleomycin (BLM, 5 mg/kg) and/or paracetamol (200 
mg/kg) on tumor size after 10 days treatment. 
Treatment 
Tumor size (mm3) 
Day 0 Day 10 
ΔT/ΔC 
(%) 
% inhibition 
Control 91.7 ± 5.3 313.0 ± 28.4 100 0 
BLM  87.5  ± 16.6 129.7 ± 24.6* 19 81 
Paracetamol 97.11 ± 4.7 302.81 ± 17.6 93 7 
BLM/ 
Paracetamol 
74.80 ± 8.2 89.80 ± 13.5* 7 93 
 
* significantly different from control group at day 10 using One-Way 
ANOVA followed by Tukey-Kramer multiple comparisons test (p<0.05). 
 
3.3. Effect of BLM and/or paracetamol on the % 
survival of rats after 4 weeks treatment 
At the end of the experiment, rats treated with 
saline and paracetamol, showed 100% survival. Rats 
treated with BLM showed a significant decrease in the 
percent survival (75%) compared to control non-treated 
rats. Administration of BLM with paracetamol showed a 
non-significant change in the percent survival of animals 
(75%) compared to BLM alone (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1      Effect of bleomycin (BLM, 15 mg/kg) and/or paracetamol (150 
mg/kg) on the percent survival of rats after 4 weeks 
treatment. 
*Significantly different from control group using chi-square 
test (p<0.05). 
 
Treatment % survival 
Control 98.0 ± 0.3 
BLM 49.0 ± 0.5* 
Paracetamol 96.0 ± 0.6 
BLM/ Paracetamol 48.0  ± 1.3* 
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3.4. Effect of BLM and/or paracetamol on body 
weight and lung/body weight ratio 
The average body weight of normal control 
animals increased significantly after 4 weeks (37% 
increase). Administration of BLM alone induced a 
significant decrease in the average body weight (29% 
reduction). Paracetamol-treated group showed a similar 
increase as in the control group. Animals treated with 
BLM and paracetamol showed a significant decrease in 
their body weight by 37% which is non-significantly 
different from BLM-treated animals. 
LM administration either alone or in combination 
with paracetamol showed a significant increase in 
lung/body weight ratio of the rats compared to control 
animals (table 3). 
 
Table 3.    Effect of bleomycin (BLM, 15 mg/kg) and/or paracetamol 
(150 mg/kg) on body weight and lung/body weight ratio of 
rats after 4 weeks treatment. 
Treatment 
Body weight (g) 
Lung/body  
weight ratio  
(  10-3 ) 
Before 
treatment 
After 
treatment 
Control 100.0  2.1 137.4  4.4° 6.9  0.15 
BLM  
 
136.3  5.4 96.7  5.5° 9.0  0.36* 
Paracetamol 160.3  6.4 196.4  7.6° 6.7  0.27 
BLM/ 
Paracetamol 
123.1  3.0 77.2  4.5° 9.2  0.32* 
 
° significantly different from its corresponding initial value using paired 
Student's t-test (p<0.05). 
* significantly different from control group using One-Way ANOVA 
followed by Tukey-Kramer multiple comparisons test (p<0.05). 
 
3.5. Effect of BLM and/or paracetamol on the 
contractile response of pulmonary arterial rings 
of rats to 5-HT  
Administration of BLM alone induced a significant 
decrease in 5-HT-induced contraction at all 
concentrations used (10-7 - 10-5 M) when compared to 
saline-treated rats. Rats treated with paracetamol 
showed a non-significant change in 5-HT-induced 
contraction at all concentrations used when compared 
to control group. A significant decrease in 5-HT-induced 
contraction at all concentrations used was produced 
when BLM was administered with paracetamol. The 
decrease was not significant from BLM alone (figure 2A). 
 
3.6. Effect of BLM and/or paracetamol on the 
contractile response of tracheal strips of rats to 
ACh  
Administration of BLM alone produced a 
significant increase in ACh-induced contraction at 
concentrations 10-6 and 10-5 M when compared to control 
group. Rats treated with paracetamol showed a non-
significant change in ACh-induced contraction at all 
concentrations used when compared to control group. 
Administration of BLM with paracetamol showed a 
significant increase in ACh-induced contraction at 10-6 
and 10-5 M with respect to control group (figure 2B). 
 
3.7. Effect of BLM and/or paracetamol on lung 
content of hydroxyproline, TBARS, GSH, SOD and 
nitrate/nitrite after 4 weeks treatment 
BLM treatment resulted in a significant increase in 
lung hydroxyproline content, TBARS and a significant 
decrease in lung GSH level compared to control non-
treated group. Administration of paracetamol with BLM 
did not significantly change the measured parameters 
when compared to BLM alone (Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Effect of bleomycin (BLM, 15 mg/kg) and/or paracetamol (150 mg/kg) on the contractile response of pulmonary arterial rings of rats to 5-
HT [A] and tracheal strips to ACh [B] after 4 weeks treatment. 
* significantly different from control group using One-Way ANOVA followed by Tukey-Kramer multiple comparisons test (p<0.05).  
A B 
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4. Discussion 
 
BLM is one of the most effective 
chemotherapeutic agents used in treatment of cancers 
of skin, penis, head, neck, lung, oesophageal carcinoma, 
malignant lymphomas, testicular carcinoma and 
malignant pleural effusions (Lazo and Chabner, 1996).  
In this study, it was found that EAC cells are 
sensitive to BLM in a concentration-dependent manner. 
This observation is in agreement with the previously 
reported cytotoxicity of BLM on many other cultured 
experimental tumor cell lines such as V 79 fibroblasts 
and P 31 human lung cancer cell lines (Benham Motlagh 
et al., 1995) and human lung cancer cell lines DLKP, A 
549, COR L23P and COR L23 R (Duffy et al., 1998). The 
cytotoxicity of BLM is believed to be through oxygen 
radical-mediated mechanisms (Bachur et al., 1978). 
Paracetamol was found to be non-cytotoxic in vitro at 
the concentration used and had no effect on BLM-
induced inhibition of survival of EAC cells.  This finding is 
consistent with the results of Heldestad et al. (1998).  
They found that acetaminophen (10 or 100 mg/L) was 
without effect on BLM cytotoxicity on Chinese hamster 
cultured fibroblasts (V 79). Thus, a combination of 
paracetamol with BLM was found to have no additional 
cytotoxic effect, indicating that BLM cytotoxicity is not 
modified by pretreatment with paracetamol. 
This study has been extended further to explore if 
paracetamol could alter the antitumor effects of BLM in 
vivo and thus, modify its therapeutic activity. In this 
sense, a mouse model of solid tumor was used. The 
antitumor activity of BLM was evidenced by the 
reduction in the relative tumor size-compared to 
untreated tumor-bearing control animals. This is coping 
with previous studies in mice-bearing solid tumors such 
as Ehrlich carcinoma, B16 melanoma and Meth A 
fibrosarcoma (Yokoyama et al., 1991), Sarcoma-180 and 
Ehrlich carcinoma (Raja Naresh et al., 1996). BLM 
significantly decreased body weight of mice, a result in 
agreement with previous studies (Tanino et al., 2002; 
Genovese et al., 2005a).  
Paracetamol did not interfere with BLM-induced 
antitumor activity in EAC-bearing mice meaning that 
BLM retains its full antitumor effectiveness in the 
presence of paracetamol.  
The clinical usefulness of BLM has been, however, 
limited by detrimental side effects. Pulmonary fibrosis 
has been considered the dose limiting toxicity of the 
drug (Coker and Laurent, 1998). Therefore, it was of 
great interest to address whether or not paracetamol 
would have effects on BLM-induced lung toxicity. In the 
present study, BLM administration significantly 
decreased the body weight of rats, an observation 
agreed with others (Gong et al., 2004; Genovese et al., 
2005b) Concomitant administration of BLM and 
paracetamol did not alter this effect. In addition, the 
results of this study revealed a significant increase in 
lung/body weight ratio of rats treated with BLM. 
Consistent with this observation, rats treated with 
intratracheal BLM developed a significant increase in 
mean    lung    wet/dry    weight   ratio   confirming   the  
 
development of pulmonary edema (Crawley et al., 1992; 
Habib et al., 1993). Concomitant administration of 
paracetamol with BLM did not alter this effect. It has 
been reported that after chronic exposure to BLM, body 
weight loss and an increase in the lung/body weight ratio 
are signs of lung toxicity (EL-Khatib, 2002). In the 
present study, administration of BLM resulted in a 
significant reduction in the percent survival of rats. This 
result is consistent with the results of others (Tanino et 
al., 2002; Genovese et al., 2005a).  
The combined use of paracetamol with BLM 
exhibited no significant change in the percent survival of 
rats when compared to BLM alone.  
BLM reduced significantly the response of 
isolated pulmonary arterial rings to 5-HT at all 
concentrations tested (10-7 to 10-5 M). These results are 
consistent with another study (EL-Khatib et al., 2001). 
Paracetamol did not alter the suppressor effect of BLM 
on 5-HT-induced pulmonary artery contraction.  
Moreover, BLM increased significantly the 
response of isolated tracheal strips to ACh at 
concentrations 10-6 and 10-5 M. This result may be due to 
overexpression of acetylcholine receptors in fibrotic lung 
after BLM treatment. In the present study, paracetamol 
did not alter the effect of BLM on ACh-induced tracheal 
smooth muscle contraction.  
Administration of BLM at a fibrogenic dose 
resulted in lung fibrosis clearly identified by biochemical 
parameters. BLM produced a significant increase in lung 
content of hydroxyproline. This observation is consistent 
with other reports (Pardo et al., 2003; Liu et al., 2005). 
Administration of paracetamol with BLM showed a 
similar increase in lung hydroxyproline content when 
compared to control value, while there was no 
significant change when compared to BLM alone.  
In the present study, the production of 
malondialdehyde, which is an index of lipid peroxidation 
was increased after BLM treatment, a result which is 
agreed with many reported data that demonstrated 
apparent elevation in lung TBARS following 
administration of BLM (Daba et al., 2002; Gong et al., 
2004).  
Administration of BLM also reduced the lung 
content of GSH and this is in line with other reports 
(Arslan et al., 2002; Pardo et al., 2003). Reduced GSH 
level observed after BLM administration could be 
indirectly attributed to the increased level of TBARS.  
BLM increased the lung activity of SOD, but it 
didn’t reach a significant level. The level of nitrate and 
nitrite measured in the lung of BLM-treated group 
showed no significant change from the control, a finding 
in agreement with that of El-Khatib et al. (2001). The use 
of paracetamol with BLM did not significantly change 
the measured parameters when compared to BLM 
group.  
Taken together, the results of the present study 
indicate the safe use of paracetamol with BLM. 
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